HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Denial Of Mucinex Petition Stops Reckitt's Bid To Delay Generics

This article was originally published in The Tan Sheet

Executive Summary

FDA stymies Reckitt Benckiser's attempt to delay private label competition for Mucinex OTC cough products by rejecting the firm's request to redefine bioequivalence standards for guaifenesin generics

You may also be interested in...



J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics

Quality control problems for Johnson & Johnson's McNeil Consumer Healthcare business and the regulatory and congressional scrutiny that followed dominated the attention of drug and dietary supplement industry stakeholders in 2010.

Reckitt Mucinex Patent Gets Reprieve As Appeals Court Rules Against Perrigo

An appeals court decision against Perrigo further delays the private labeler's plans to launch a Mucinex equivalent, leaving the Reckitt Benckiser decongestant still unchallenged by generic competition

Reckitt's Lysol Innovation Leads Launches As Acquisition Talk Subsides

Reckitt Benckiser looks to continue feeding organic growth through innovative product launches, as discussion of the company's acquisition search has quieted in recent months

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS135293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel